Literature DB >> 12477752

Ablative mucosectomy is the procedure of choice to prevent Barrett's cancer.

R C Fitzgerald1.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12477752      PMCID： PMC1773508          DOI： 10.1136/gut.52.1.16

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  20 in total

Review 1.  Is there publication bias in the reporting of cancer risk in Barrett's esophagus?

Authors:  N J Shaheen; M A Crosby; E M Bozymski; R S Sandler
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

2.  Successful reversal of Barrett's esophagus with multipolar electrocoagulation despite inadequate acid suppression.

Authors:  B J Kovacs; Y K Chen; T D Lewis; L J DeGuzman; K S Thompson
Journal:  Gastrointest Endosc       Date:  1999-05       Impact factor: 9.427

3.  Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study.

Authors:  R E Sampliner; D Faigel; M B Fennerty; D Lieberman; A Ippoliti; K Lewin; W M Weinstein
Journal:  Gastrointest Endosc       Date:  2001-05       Impact factor: 9.427

4.  KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus.

Authors:  L Gossner; A May; M Stolte; G Seitz; E G Hahn; C Ell
Journal:  Gastrointest Endosc       Date:  1999-01       Impact factor: 9.427

5.  Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology.

Authors:  R E Sampliner
Journal:  Am J Gastroenterol       Date:  1998-07       Impact factor: 10.864

6.  Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients.

Authors:  B F Overholt; M Panjehpour; J M Haydek
Journal:  Gastrointest Endosc       Date:  1999-01       Impact factor: 9.427

Review 7.  Review article: Barrett's oesophagus, dysplasia and pharmacologic acid suppression.

Authors:  R C Fitzgerald; R Lascar; G Triadafilopoulos
Journal:  Aliment Pharmacol Ther       Date:  2001-03       Impact factor: 8.171

8.  Durability of new squamous epithelium after endoscopic reversal of Barrett's esophagus.

Authors:  P Sharma; A Bhattacharyya; H S Garewal; R E Sampliner
Journal:  Gastrointest Endosc       Date:  1999-08       Impact factor: 9.427

9.  Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus.

Authors:  J L Van Laethem; M O Peny; I Salmon; M Cremer; J Devière
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

10.  Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation.

Authors:  C D Morris; J P Byrne; G R Armstrong; S E Attwood
Journal:  Br J Surg       Date:  2001-10       Impact factor: 6.939
View more
  2 in total

1.  INK4a-ARF alterations in Barrett's epithelium, intraepithelial neoplasia and Barrett's adenocarcinoma.

Authors:  Michael Vieth; Regine Schneider-Stock; Knut Röhrich; Andrea May; Christian Ell; Anett Markwarth; Albert Roessner; Manfred Stolte; Andrea Tannapfel
Journal:  Virchows Arch       Date:  2004-06-08       Impact factor: 4.064

2.  Barrett's oesophagus and adenocarcinoma.

Authors:  Christine P J Caygill; Anthony Watson; Pierre Lao-Sirieix; Rebecca C Fitzgerald
Journal:  World J Surg Oncol       Date:  2004-05-07       Impact factor: 2.754
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.